CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 8 incoming connections
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
3.78BCNY561.97M · vs all stocks (USD)
Revenue (TTM)
330.96MCNY49.22M · vs all stocks (USD)
Profit Margin
-5.92%vs Medical Devices peers
Beta
0.4190xvs all stocks
52-Week Change
48.32%vs all stocks
Market Capitalization
3.78BCNY561.97M · vs all stocks (USD)
Enterprise Value
3.45BCNY513.50M · vs all stocks (USD)
Forward P/E
69.18xvs Medical Devices peers
Price to Sales (TTM)
11.78xvs Medical Devices peers
Price to Book (MRQ)
4.61xvs Medical Devices peers
Enterprise to Revenue
10.43xvs Medical Devices peers
Gross Margin
35.49%vs Medical Devices peers
Profit Margin
-5.92%vs Medical Devices peers
Operating Margin
-12.82%vs Medical Devices peers
Return on Assets (TTM)
-0.85%vs Medical Devices peers
Return on Equity (TTM)
-2.48%vs Medical Devices peers
Revenue (TTM)
330.96MCNY49.22M · vs all stocks (USD)
Revenue per Share (TTM)
3.93CNYUpdated Aug 21, 2026Quarterly Revenue Growth
17.30%vs Medical Devices peers
Gross Profit (TTM)
113.41MCNY16.86M · vs all stocks (USD)
EBITDA (TTM)
21.30MCNY3.17M · vs all stocks (USD)
Net Income (TTM)
-19.59MCNY-2.91M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-33.20%vs Medical Devices peers
Operating Cash Flow (TTM)
-54.81MCNY-8.15M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-122.37MCNY-18.20M · vs all stocks (USD)
Payout Ratio
101.67%vs Medical Devices peers
Minority Interest (Equity)
-803.12KCNYFY2025 · Dec 31, 2025Revenue
320.86MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
203.30MCNYFY2025 · Dec 31, 2025Gross Profit
117.56MCNYFY2025 · Dec 31, 2025Operating Income
19.99MCNY2.97M · vs all stocks (USD)
Pre-tax Income
-9.48MCNYFY2025 · Dec 31, 2025Income Tax Expense
-2.16MCNYFY2025 · Dec 31, 2025Net Income
-7.33MCNYFY2025 · Dec 31, 2025EBIT
-8.53MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
21.30MCNYFY2025 · Dec 31, 2025Research & Development
32.05MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
20.38MCNYFY2025 · Dec 31, 2025Other Operating Expenses
1.14MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
675.78KCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
950.25KCNYFY2025 · Dec 31, 2025EPS (Basic)
-0.0800CNYFY2025 · Dec 31, 2025EPS (Diluted)
-0.0800CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
83.34MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
83.34MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-7.33MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
662.13KCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-113.21MCNYFY2025 · Dec 31, 2025Free Cash Flow
-178.88MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
212.02MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-7.33MCNYFY2025 · Dec 31, 2025Other Non-cash Items
5.72MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-32.04MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-79.56MCNYFY2025 · Dec 31, 2025Capital Expenditures
-65.67MCNYFY2025 · Dec 31, 2025Purchase of Investments
-38.00MCNYFY2025 · Dec 31, 2025Sale of Investments
4.55MCNYFY2025 · Dec 31, 2025Other Investing Activity
144.36MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
45.23MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
67.34MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-37.59MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-5.95MCNYFY2025 · Dec 31, 2025Other Financing Charges
-4.29MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
19.50MCNYFY2025 · Dec 31, 2025Shares Outstanding
88.13MSharesUpdated Aug 21, 2026Float Shares
59.43MSharesUpdated Aug 21, 2026% Held by Insiders
39.82%vs all stocks
% Held by Institutions
5.21%vs all stocks
Total Cash (MRQ)
225.40MCNY33.52M · vs all stocks (USD)
Total Cash per Share (MRQ)
2.58CNYUpdated Aug 21, 2026Total Debt (MRQ)
52.41MCNY7.79M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0625xvs Medical Devices peers
Current Ratio (MRQ)
4.66xvs Medical Devices peers
Book Value per Share (MRQ)
9.61CNYUpdated Aug 21, 2026Total Assets
977.93MCNY145.43M · vs all stocks (USD)
Total Current Assets
532.17MCNYFY2025 · Dec 31, 2025Total Liabilities
124.52MCNYFY2025 · Dec 31, 2025Total Non-current Assets
445.75MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
13.08MCNYFY2025 · Dec 31, 2025Total Current Liabilities
111.44MCNYFY2025 · Dec 31, 2025Cash
212.02MCNYFY2025 · Dec 31, 2025Cash Equivalents
1.39MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
213.41MCNYFY2025 · Dec 31, 2025Other Short-term Investments
30.04MCNYFY2025 · Dec 31, 2025Accounts Receivable
111.55MCNYFY2025 · Dec 31, 2025Inventory
151.75MCNYFY2025 · Dec 31, 2025Accounts Payable
57.17MCNYFY2025 · Dec 31, 2025Short-term Debt
35.71MCNYFY2025 · Dec 31, 2025Other Current Liabilities
542.76KCNYFY2025 · Dec 31, 2025Long-term Debt
6.77MCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
2.02MCNYFY2025 · Dec 31, 2025Common Stock (Book)
88.13MCNYFY2025 · Dec 31, 2025Retained Earnings
189.54MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
853.41MCNY126.91M · vs all stocks (USD)
Treasury Stock
10.00MCNYFY2025 · Dec 31, 202552-Week Low
25.80CNYUpdated Aug 21, 202652-Week High
73.00CNYUpdated Aug 21, 202652-Week Change
48.32%vs all stocks
Beta
0.4190xvs all stocks
50-Day MA
45.66CNYUpdated Aug 21, 2026200-Day MA
50.95CNYUpdated Aug 21, 2026Avg 10-Day Volume
2.06MSharesUpdated Aug 21, 2026Avg 30-Day Volume
2.56MSharesUpdated Aug 21, 2026Diluted EPS (TTM)
-0.2300CNYUpdated Aug 21, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Supply Chain
Midstream position: 6 outgoing, 8 incoming connectionsNotable
Outgoing: 6.00Incoming: 8.00
High connectivity hub: 14 industry connectionsNotable
Total Connections: 14.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Jiangsu Sihuan Bioengineering Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Wuhan Hiteck Biological Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Shandong Sinobioway Biomedicine Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Shaanxi Kanghui Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
CHA Biotech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleInterface
Prime Medicine Inc.
Tier 1ProductionApproval-Gated PipelineRule
Shanghai Aohua Photoelectricity Endoscope Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Boryung Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Assure Tech Hangzhou Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Orchid Pharma Ltd.
Tier 1ProductionApproval-Gated PipelineRule